Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials

Z Niu, R Jin, Y Zhang, H Li - Signal Transduction and Targeted Therapy, 2022 - nature.com
Lung cancer is the leading cause of cancer-related death across the world. Unlike lung
adenocarcinoma, patients with lung squamous cell carcinoma (LSCC) have not benefitted …

[HTML][HTML] The role of SOX family members in solid tumours and metastasis

D Grimm, J Bauer, P Wise, M Krüger… - Seminars in cancer …, 2020 - Elsevier
Cancer is a heavy burden for humans across the world with high morbidity and mortality.
Transcription factors including sex determining region Y (SRY)-related high-mobility group …

Functional characterization of SOX2 as an anticancer target

S Zhang, X Xiong, Y Sun - Signal transduction and targeted therapy, 2020 - nature.com
SOX2 is a well-characterized pluripotent factor that is essential for stem cell self-renewal,
reprogramming, and homeostasis. The cellular levels of SOX2 are precisely regulated by a …

SOX2 and cancer: current research and its implications in the clinic

K Weina, J Utikal - Clinical and translational medicine, 2014 - Springer
SOX2 is a gene that encodes for a transcription factor belonging to the SOX gene family and
contains a high-mobility group (HMG) domain, which permits highly specific DNA binding …

[HTML][HTML] SOX2 function in cancers: Association with growth, invasion, stemness and therapy response

S Mirzaei, MDA Paskeh, M Entezari… - Biomedicine & …, 2022 - Elsevier
Cancer is a leading cause of death worldwide and around 10 million deaths in 2020 were
related to cancer. There are a number of therapeutic modalities for cancer such as …

Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication

S Kaufhold, H Garbán, B Bonavida - Journal of Experimental & Clinical …, 2016 - Springer
Abstract The transcription factor Yin Yang 1 (YY1) is frequently overexpressed in cancerous
tissues compared to normal tissues and has regulatory roles in cell proliferation, cell …

SOX2 mediates metabolic reprogramming of prostate cancer cells

L de Wet, A Williams, M Gillard, S Kregel, S Lamperis… - Oncogene, 2022 - nature.com
New strategies are needed to predict and overcome metastatic progression and therapy
resistance in prostate cancer. One potential clinical target is the stem cell transcription factor …

Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment

Z Liu, M Xiong, J Gong, Y Zhang, N Bai, Y Luo… - Nature …, 2014 - nature.com
Specific targeting and cellular internalization are key properties for carriers of antitumor
therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of …

[HTML][HTML] IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer

W Gao, H Wen, L Liang, X Dong, R Du, W Zhou… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Tumor microenvironment interacts with tumor cells to regulate their stemness
properties through various cytokines and cytokine receptors. Previous studies revealed the …

METTL3‐stabilized super enhancers‐lncRNA SUCLG2‐AS1 mediates the formation of a long‐range chromatin loop between enhancers and promoters of SOX2 in …

X Hu, J Wu, Y Feng, H Ma, E Zhang… - Clinical and …, 2023 - Wiley Online Library
Background Super enhancers (SE) play pivotal roles in cell identity and diseases occur
including tumorigenesis. The depletion of SE‐associated lncRNA transcripts, also known as …